Canada markets close in 1 hour 31 minutes

Hamilton Thorne Ltd. (HTL.V)

TSXV - TSXV Real Time Price. Currency in CAD
Add to watchlist
1.65000.0000 (0.00%)
As of 09:30AM EDT. Market open.
Full screen
Previous Close1.6500
Open1.6500
Bid1.6500 x 0
Ask1.6900 x 0
Day's Range1.6500 - 1.6500
52 Week Range1.3100 - 2.2000
Volume5,500
Avg. Volume30,749
Market Cap238.285M
Beta (5Y Monthly)0.83
PE Ratio (TTM)55.00
EPS (TTM)0.0300
Earnings DateNov 21, 2022 - Nov 25, 2022
Forward Dividend & YieldN/A (N/A)
Ex-Dividend DateN/A
1y Target Est2.62
  • GlobeNewswire

    Hamilton Thorne to Participate in the 6th Annual Lake Street Capital Markets Best Ideas Growth Conference

    BEVERLY, Mass. and TORONTO, Sept. 02, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that the Company will participate in the 6th Annual Lake Steet Capital Markets Best Ideas Growth Conference being held at the Yale Club in New York, NY on September 14, 2022. David Wolf, President and CEO, and Francesco F

  • GlobeNewswire

    Hamilton Thorne Reports Financial and Operational Results for the Quarter and Six Months Ended June 30, 2022

    Revenues up 14% for the quarter and 18% for the six months despite supply chain issues and significant foreign currency swingsBEVERLY, Mass. and TORONTO, Aug. 23, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V:HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today reported financial and operational results for the quarter and six months ended June 30, 2022. Highlights S

  • GlobeNewswire

    Hamilton Thorne to Announce Q2 Financial Results and Hold Conference Call on August 23, 2022

    BEVERLY, Mass. and TORONTO, Aug. 16, 2022 (GLOBE NEWSWIRE) -- Hamilton Thorne Ltd. (TSX-V: HTL), a leading provider of precision instruments, consumables, software and services to the Assisted Reproductive Technologies (ART), research, and cell biology markets, today announced that it will release its financial results for the three- and six-month periods ended June 30, 2022 before market open on Tuesday, August 23, 2022. The press release, with accompanying financial information, will be posted